Traumatic injury and idiopathic avascular necrosis of the talus bone can result in osteochondral lesions of the talus leading to pain, motion loss, and disability. Treatment with osteochondral allografting currently requires the donor talus to be size matched to the recipient talus to ensure precise fits. Eliminating or reducing the need for size matching would lessen costs and the delay between diagnosis and treatment. 3D models of 12 tali of varying sizes were used to analyze curvatures and profiles of select areas on the talar dome. The allograft procedure was mimicked to compare the results between using 20mm and 30mm osteochondral allografts with, and without, donor size matching. The observed curvatures and profiles on the talar dome were found to be consistent between tali of different sizes. Size matching was not required to have acceptable levels of deviation between donor and recipient tali when using 20mm length segments. Deviations without size matching were found to be very similar to the deviations with size matching with only 14.8% of the fits without size matching having larger deviations (although less than 1.5mm) than those with size matching. Using the 30mm segments, there was a significant difference between the small female tali and the largest male tali. Thus, donor size matching is not necessary when treating large osteochondral lesions of the talus with an osteochondral allograft taken from the central 20mm of the donor talar dome, and only sex matching may be necessary for 30mm grafts.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.foot.2019.09.002 | DOI Listing |
J Dtsch Dermatol Ges
January 2025
Sheba Medical Center, Tel Hashomer, Sackler School of Medicine, Faculty of Medical and Health Sciences, Tel Aviv University, Israel.
Background And Objectives: Integration of artificial intelligence in healthcare, particularly ChatGPT, is transforming medical diagnostics and may benefit teledermatology. This exploratory study compared image description and differential diagnosis generation by a ChatGPT-4 based chatbot with human teledermatologists.
Patients And Methods: This retrospective study compared 154 teledermatology consultations (December 2023-February 2024) with ChatGPT-4's performance in image descriptions and diagnoses.
J Mech Behav Biomed Mater
January 2025
Department of Biomedical Engineering, Toronto Metropolitan University, Toronto, Canada; Sunnybrook Research Institute, Toronto, Canada.
The integration of self-expandable nitinol frames with cable-driven parallel mechanisms offers a promising advancement in minimally invasive cardiovascular interventions. This study presents the design, fabrication, and verification of a miniaturized self-expandable nitinol frame to enhance catheter tip steerability and navigation within complex vascular anatomies. The frame is reduced in size for delivery through 7-8 Fr sheaths while accommodating diverse vascular diameters, allowing up to a maximum expansion of 15 mm.
View Article and Find Full Text PDFAppl Ergon
January 2025
Chongqing Changan Automobile Co., Ltd, Chongqing, China.
In-vehicle Head-Up Displays (HUDs) are expected to incorporate more information in the future, necessitating deeper understandings of design properties that can enhance display safety and efficiency. However, the optimal display characteristics-particularly in terms of area and shape-remain inadequately understood. This study investigated these two factors by manipulating horizontal and vertical Field of View (FOV) angles within a simulated in-vehicle HUD.
View Article and Find Full Text PDFJ Thromb Haemost
January 2025
Department of Paediatrics, Medical University of Vienna, Vienna, Austria.
Introduction: The pediatric direct oral anticoagulation (DOAC) trials provide an opportunity to evaluate and characterize challenges in their design and execution to inform future antithrombotic trials.
Objective: To perform a systematic review of pediatric DOAC trials for the treatment of venous thromboembolism to critically appraise their methodology and understand the feasibility and challenges.
Methods: Systematic search of MEDLINE, EMBASE, the Cochrane Library and ClinicalTrials.
Lancet Infect Dis
January 2025
Geneva Centre for Emerging Viral Diseases, Geneva University Hospitals, Geneva, Switzerland; Médecins Sans Frontières, Geneva, Switzerland; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Division of Tropical and Humanitarian Medicine, Geneva University Hospitals, Geneva, Switzerland. Electronic address:
Background: Hepatitis E virus (HEV) is a leading cause of acute viral hepatitis, particularly in Asia and Africa, where HEV genotypes 1 and 2 are prevalent. Although a recombinant vaccine, Hecolin, is available, it has not been used to control outbreaks. The licensed three-dose regimen might pose challenges for it to be an impactful outbreak control tool.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!